Effect of Adalimumab on Ankylosing Spondylitis: A three Month Clinical Response in Indian Scenario+
Journal Title: Journal of Medical Science And clinical Research - Year 2017, Vol 5, Issue 9
Abstract
Introduction: This study aimed to evaluate the clinical response and safety in patients of Ankylosing spondylitis (AS) from a Rheumatology clinic in Madhya Pradesh, city Indore, after three months of Adalimumab therapy. All the patients who fulfilled modified New York criteria for AS were enrolled in the study. Material and Methods: A total of 82 patients completed the study. The study was done initiating Adalimumab therapy due to lack of efficacy for NSAIDs and/or DMARDs were recruited consecutively from 31st December 2016 till 31st July 2017 in a Rheumatology clinic. The patients were evaluated for disease activity using the BASDAI which assesses fatigue, spinal pain, joint pain, joint swelling, areas of localized tenderness, and morning stiffness, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR). Functional limitation was evaluated using Bath AS Functional Activity Index (BASFI), which assesses activities related to functional anatomy, and the patient's ability to cope with everyday life .Spinal movement was evaluated using Bath AS Metrology Index (BASMI), which measures cervical rotation, tragus to wall distance, lumbar side flexion, modified Schober's, and intermalleolar distance. Result: The rate of improvement of Bath AS Disease Activity Index (BASDAI) (p< 0.0001), and Bath AS Metrology Index (BASMI) (p=0.0009) and BASFI (Bath Ankylosing spondylitis functional Index) were achieved (p value<0.001) after three months. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were significantly decreased (p< 0.0001, p<0.0001 respectively).No adverse effects were seen including tuberculosis in any of the patient. Significant improvement in Erythrocyte Sedimentaion Rate (ESR), C-Reactive Protein (CRP) was also seen after 3 months (P-value <0.001, P-value<0.001) Patients who showed inadequate response to conventional therapy for AS showed significant improvement with Adalimumab treatment in disease activity as well as inflammatory markers. Conclusion: Patients who showed inadequate response to conventional therapy for AS showed significant improvement with Adalimumab treatment in disease activity as well as inflammatory markers.
Authors and Affiliations
Dr Akshat Pandey
Keywords
Related Articles
- EP ID EP528180
- DOI -
- Views 52
- Downloads 0
Profile of Seizure in Elderly Population Attending Rural Tertiary Care Centre of Central India
Background: Epilepsy is a major health problem in developing countries including India. The epilepsy incidence has been steadily increasing by average annual rate of 3.5% in the elderly population over the past 2 decades...
Anticipatory Postural Adjustment of the Core Muscles during Forward Arm Reaching in Children with Spastic Diplegia
Background: Children with cerebral palsy (CP) have disorders of the development of movement and posture, and they may have difficulties achieving trunk control. Trunk control is essential for free and selective movements...
Developing a Scoring System in the Diagnosis of Tuberculous Pleural Effusion
Pleural effusion occurs in approximately 5% of patients with tuberculosis. Since tuberculous pleural effusion is paucibacillary in nature, demonstration of AFB bacilli will not be possible in most of the cases, which mak...
Study of Factors Associated with Success of Vaginal Birth after Previous One Caesarean Section
Background: A women with previous caesarean birth has two options in her subsequent delivery, either planned elective repeat caesarean or planned vaginal birth. Both the options are associated with risks and benefits. Ai...
Assessment of Family Physician’s Knowledge, Attitude and Barriers to the use of Oral Anticoagulation Therapy among Atrial Fibrillation Patients in Riyadh City
Background: Atrial fibrillation (AF) is the most common arrhythmia type. The prevalence of AF is associated with different factors such as age, body mass index (BMI), physical activity, genetic factors and lifestyle fact...